Literature DB >> 7787780

Unstable triplet repeat sequences: a source of cancer mutations?

S Panzer1, D P Kuhl, C T Caskey.   

Abstract

Numerous mutations have been related to various types of cancer. Short tandem repeats (STRs) are repetitive DNA elements that are often polymorphic in normal populations. Triplet repeat expansion has been related pathogenetically to six diseases: fragile X syndrome, fragile X E syndrome, spinobulbar muscular atrophy, myotonic dystrophy, Huntington's disease, and spinocerebellar ataxia type 1. The characteristics of the GC-rich repeat expansion are diverse and result in profound changes in phenotype, sometimes within a single generation in affected families. We expect that simple repeat expansion will cause some cancers based on our knowledge of these unstable DNA sequences in the previously mentioned genes. This may occur by alteration of tumor suppressor gene expression, alteration in coding features of proteins, or change in bystander oncogene expression such as that which occurs with DNA methylation. The demonstrated meiotic instability could link this mechanism of mutation of familial cancer syndromes. The recent discovery of STR instability at multiple sites in hereditary nonpolyposis colon cancer suggests sequence instability may be a factor in cancer progression. Continued identification of candidate genes containing triplet repeats should allow a ready testing of the hypothesis that unstable simple repeat sequences can cause cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7787780     DOI: 10.1002/stem.5530130206

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  6 in total

1.  Cancer risk among patients with myotonic muscular dystrophy.

Authors:  Shahinaz M Gadalla; Marie Lund; Ruth M Pfeiffer; Sanne Gørtz; Christine M Mueller; Richard T Moxley; Sigurdur Y Kristinsson; Magnus Björkholm; Fatma M Shebl; James E Hilbert; Ola Landgren; Jan Wohlfahrt; Mads Melbye; Mark H Greene
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

2.  Anticipation in familial leukemia.

Authors:  M Horwitz; E L Goode; G P Jarvik
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

3.  Benign and malignant tumors in the UK myotonic dystrophy patient registry.

Authors:  Rotana Alsaggaf; Youjin Wang; Chiara Marini-Bettolo; Libby Wood; Nikoletta Nikolenko; Hanns Lochmüller; Mark H Greene; Shahinaz M Gadalla
Journal:  Muscle Nerve       Date:  2017-07-24       Impact factor: 3.217

4.  Correlates of tumor development in patients with myotonic dystrophy.

Authors:  Maya Das; Richard T Moxley; James E Hilbert; William B Martens; Lisa Letren; Mark H Greene; Shahinaz M Gadalla
Journal:  J Neurol       Date:  2012-05-23       Impact factor: 4.849

5.  Cancer Risk in Patients With Fuchs Endothelial Corneal Dystrophy.

Authors:  Timothy T Xu; Keith H Baratz; Michael P Fautsch; David O Hodge; Michael A Mahr
Journal:  Cornea       Date:  2021-09-27       Impact factor: 3.152

6.  DMSO and betaine greatly improve amplification of GC-rich constructs in de novo synthesis.

Authors:  Michael A Jensen; Marilyn Fukushima; Ronald W Davis
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.